XENOGEN CORP·4

Aug 14, 12:16 PM ET

XENOGEN CORP 4

4 · XENOGEN CORP · Filed Aug 14, 2006

Insider Transaction Report

Form 4
Period: 2006-08-09
Transactions
  • Disposition to Issuer

    Common Stock

    2006-08-091,300,1170 total(indirect: By Abingworth Bioventures III A L.P.)
  • Disposition to Issuer

    Common Stock

    2006-08-09793,6410 total(indirect: By Abingworth Bioventures III B L.P.)
  • Disposition to Issuer

    Common Stock

    2006-08-0920,7190 total(indirect: By Abingworth Bioventures III Executives L.P.)
  • Disposition to Issuer

    Warrant (Right to Buy)

    2006-08-09129,3810 total(indirect: By Abingworth Bioventures III A L.P.)
    Exercise: $3.29From: 2006-02-15Exp: 2010-08-15Common Stock (129,381 underlying)
  • Disposition to Issuer

    Common Stock

    2006-08-09515,4640 total(indirect: By Abingworth Bioequities Master Fund Limited)
  • Disposition to Issuer

    Warrant (Right to Buy)

    2006-08-092,0620 total(indirect: By Abingworth Bioventures III Executives L.P.)
    Exercise: $3.29From: 2006-02-15Exp: 2010-08-15Common Stock (2,062 underlying)
  • Disposition to Issuer

    Common Stock

    2006-08-09475,3980 total(indirect: By Abingworth Bioventures III C L.P.)
  • Disposition to Issuer

    Warrant (Right to Buy)

    2006-08-0947,3090 total(indirect: By Abingworth Bioventures III C L.P.)
    Exercise: $3.29From: 2006-02-15Exp: 2010-08-15Common Stock (47,309 underlying)
  • Disposition to Issuer

    Warrant (Right to Buy)

    2006-08-09154,6390 total(indirect: By Abingworth Bioequities Master Fund Limited)
    Exercise: $3.29From: 2006-02-15Exp: 2010-08-15Common Stock (154,639 underlying)
  • Disposition to Issuer

    Common Stock

    2006-08-0915,7150 total(indirect: By Abingworth Ltd.)
  • Disposition to Issuer

    Warrant (Right to Buy)

    2006-08-0978,9790 total(indirect: By Abingworth Bioventures III B L.P.)
    Exercise: $3.29From: 2006-02-15Exp: 2010-08-15Common Stock (78,979 underlying)
Footnotes (2)
  • [F1]Disposed of pursuant to an Agreement and Plan of Merger between the Issuer, Caliper Life Sciences, Inc. ("Caliper") and Caliper Holdings, Inc. (the "Merger"). In exchange for each share of Issuer common stock, stockholders of the Issuer received .5792 shares of Caliper Common Stock, having a market value of $4.84 (the closing sale price) per share on the effective date of the Merger and a Warrant to purchase .2249 of a share of Caliper Common Stock.
  • [F2]This warrant was assumed by Caliper in the Merger and replaced with a warrant to purchase .5792 shares of Caliper common stock for each Issuer warrant share at an exercise price of $4.84 (closing sale price) per share.

Documents

1 file
  • 4
    rrd126373.xmlPrimary

    MERGER FORM 4